Schedule 13D ownership disclosure

Cytek Biosciences Inc

Security class unavailable · CUSIP: 23285D109

Event date: 2023-09-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,809,404
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-101999
Form type
SC 13D/A
Filer
Cytek Biosciences, Inc.
CIK
CIK 1831915
Filed
Sep 19, 2023
Reporting period
Sep 15, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub